Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GILES, Thomas")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 59

  • Page / 3
Export

Selection :

  • and

The Role of Vasodilating β-Blockers in Patients with Complicated Hypertension: Focus on NebivololGILES, Thomas D.The American journal of medicine. 2010, Vol 123, Num 7A, issn 0002-9343, S16-S20, SUPArticle

Examining therapeutic goals: Population versus individual-based approachesGILES, Thomas D.American journal of hypertension. 2003, Vol 16, Num 11, pp 26S-30S, issn 0895-7061, 2Conference Paper

Management of heart failure in patients with diabetes mellitusGILES, Thomas D.Cardiovascular reviews & reports. 2002, Vol 23, Num 2, pp 89-95, issn 0197-3118Article

Atherosclerotic Cardiovascular Disease: New Approaches to Risk Assessment and InterventionGILES, Thomas D.The American journal of medicine. 2002, Vol 112, Num 8A, issn 0002-9343, 43 p.Conference Proceedings

New directions in hypertension: beyond JNC VIGILES, Thomas D.American journal of hypertension. 2003, Vol 16, Num 11, issn 0895-7061, 32 p., 2Conference Proceedings

β-Blockers: Mechanistic Explanations for Class Pharmacodynamic and Therapeutic HeterogeneityGILES, Thomas D.The American journal of medicine. 2010, Vol 123, Num 7A, issn 0002-9343, 30 p., SUPSerial Issue

Pharmacologic and clinical perspectives on mibefradil: a new T-channel selective calcium antagonistGILES, Thomas D.The American journal of cardiology. 1997, Vol 80, Num 4B, issn 0002-9149, 48 p.Serial Issue

Recommendations for the management of special populations: Renal disease in diabetesRAIJ, Leopoldo.American journal of hypertension. 2003, Vol 16, Num 11, pp 46S-49S, issn 0895-7061, 2Conference Paper

Results of the prothrombin office-testing benefit evaluation (PROBE)GILES, Thomas D; ROFFIDAL, Louise.Cardiovascular reviews & reports. 2002, Vol 23, Num 1, pp 27-33, issn 0197-3118, 5 p.Article

Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapyOPARIL, Suzanne; GILES, Thomas; OFILI, Elizabeth O et al.Journal of hypertension. 2011, Vol 29, Num 1, pp 161-170, issn 0263-6352, 10 p.Article

Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspiratesDIETRICH, Dimo; KNEIP, Christoph; SCHMIDT, Bernd et al.International journal of oncology. 2012, Vol 40, Num 3, pp 825-832, issn 1019-6439, 8 p.Article

The cost-effective way forward for the management of the patient with heart failureGILES, T.Cardiology. 1996, Vol 87, pp 33-39, issn 0008-6312, SUP1Conference Paper

Relevance of blood pressure variation in the circadian onset of cardiovascular eventsGILES, Thomas.Journal of hypertension. 2005, Vol 23, pp S35-S39, issn 0263-6352, SUP1Conference Paper

Current controversies with ACE inhibitor treatment in heart failureVISSER, F. C; VISSER, C. A.Cardiology. 1996, Vol 87, pp 23-28, issn 0008-6312, SUP1Conference Paper

Ventricular remodelingMAISCH, B.Cardiology. 1996, Vol 87, pp 2-10, issn 0008-6312, SUP1Conference Paper

The Interobserver Reproducibility of Thyroid Fine-Needle Aspiration Using the UK Royal College of Pathologists' Classification SystemKOCJAN, Gabrijela; CHANDRA, Ashish; CROSS, Paul A et al.American journal of clinical pathology. 2011, Vol 135, Num 6, pp 852-859, issn 0002-9173, 8 p.Article

Identification, diagnosis and treatment of heart failure : could we do better ?STRUTHERS, A. D.Cardiology. 1996, Vol 87, pp 29-32, issn 0008-6312, SUP1Conference Paper

Interruption of the progression of heart failure : are ACE inhibitors the solution ?COATS, A.Cardiology. 1996, Vol 87, pp 11-15, issn 0008-6312, SUP1Conference Paper

Myocardial infarction : when and how should we initiate treatment with ACE inhibitors ?LATINI, R; MAGGIONI, A. P; ZUANETTI, G et al.Cardiology. 1996, Vol 87, pp 16-22, issn 0008-6312, SUP1Conference Paper

Effect of Dronedarone on Exercise Capacity and Cardiac Function in Patients With Severe Left Ventricular Dysfunction and Compensated Stable Heart FailureBARRY LEVINE, T; GILES, Thomas; RADZIK, David et al.Cardiovascular drugs and therapy. 2010, Vol 24, Num 5-6, pp 449-458, issn 0920-3206, 10 p.Article

Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care settingWHITE, William B; GILES, Thomas; BAKRIS, George L et al.The American heart journal. 2005, Vol 151, Num 1, pp 176-184, issn 0002-8703, 9 p.Article

Angiotensin receptor blockers : Evidence for preserving target organsCARSON, Peter; GILES, Thomas; HIGGINBOTHAM, Michael et al.Clinical cardiology (Mahwah, NJ). 2001, Vol 24, Num 3, pp 183-190, issn 0160-9289Article

ACE inhibitors in heart failure : advancing clinical practice. Satellite symposiumDAVIES, Michael K; GILES, Thomas.Cardiology. 1996, Vol 87, issn 0008-6312, 47 p., SUP1Conference Proceedings

One Size Does Not Fit All: The Role of Vasodilating β-Blockers in Controlling Hypertension as a Means of Reducing Cardiovascular and Stroke RiskBASILE, Jan N.The American journal of medicine. 2010, Vol 123, Num 7A, issn 0002-9343, S9-S15, SUPArticle

Effects of Olmesartan medoxomil on systolic blood pressure and pulse pressure in the management of hypertensionGILES, Thomas D; ROBINSON, Thomas D.American journal of hypertension. 2004, Vol 17, Num 8, pp 690-695, issn 0895-7061, 6 p.Article

  • Page / 3